FDMT 4D Molecular Therapeutics, Inc.: institutional ownership and insider trading
168 funds reported holding $851M of 4D Molecular Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $136M, with 32 new positions and 23 funds selling out; over the last 12 months insiders bought $0 and sold $5.35M on the open market.
Famous investors holding FDMT
- Renaissance Technologies (Renaissance Technologies): $8.17M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $12.0M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $924K, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $590K, 0.0% of the portfolio
Largest institutional holders of FDMT
- Jupiter Topco LLC — $76.5M
- RA CAPITAL MANAGEMENT, L.P. — $67.2M
- BlackRock, Inc. (BLK) — $60.5M
- GOLDMAN SACHS GROUP INC (GS, GSCE, GS-PA, GS-PC, GS-PD) — $56.6M
- JANUS HENDERSON GROUP PLC (JHG) — $48.9M
- Novo Holdings A/S — $43.2M
- STATE STREET CORP (STT, STT-PG) — $38.7M
- BVF INC/IL — $38.3M
- T. Rowe Price Investment Management, Inc. — $33.4M
- ADAGE CAPITAL PARTNERS GP, L.L.C. — $29.9M
Recent FDMT insider trades
- Oct 16, 2026: Bizily Scott sold 1,635 shares ($21.0K)
- Oct 5, 2026: Kirn David sold 58,333 shares ($754K)
- Sep 16, 2026: Bizily Scott sold 1,635 shares ($22.3K)
- Sep 14, 2026: Kirn David sold 58,333 shares ($811K)
5%+ owners
- JANUS HENDERSON GROUP PLC: 10.3% (Schedule 13G/A, filed Apr 7, 2026)
- BVF PARTNERS L P/IL: 10.0% (Schedule 13G/A, filed May 15, 2026)
- RA Capital Management, L.P.: 9.9% (Schedule 13G/A, filed May 15, 2026)
- STATE STREET CORPORATION: 5.3% (Schedule 13G, filed May 12, 2026)